Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuronal acetylcholine receptors (nAChRs) are ligand-gated ion channels that mediate fast synaptic transmission in the central and peripheral nervous systems. They are activated by the neurotransmitter acetylcholine and also respond to nicotine. nAChRs are pentameric proteins consisting of various combinations of α and β subunits, forming diverse subtypes with distinct pharmacological properties. They play key roles in synaptic plasticity, neurotransmitter release, cognitive functions, and are implicated in various neurological diseases, including Alzheimer's, schizophrenia, and addiction.
Agonist or antagonist binding to the receptor, causing a conformational change that opens or closes the ion channel.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuronal Acetylcholine Receptor (nAChR).